CIK 0001287098
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522210438
- Phone
- +1 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-02 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion | +4,438 | $0.84 | $4K | 4,438 |
| 2022-11-02 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion | +1,266 | $1.08 | $1K | 5,704 |
| 2022-11-02 | Ross Thomas M. EVP, Global Sales & Marketing | Sale | −5,704 | $6.85 | $39K | 0 |
| 2022-11-02 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion · Employee Stock Option (right to buy) | −4,438 | 0 | ||
| 2022-11-02 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion · Employee Stock Option (right to buy) | −1,266 | 60,734 | ||
| 2022-11-01 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion | +23,429 | $0.84 | $20K | 23,429 |
| 2022-11-01 | Ross Thomas M. EVP, Global Sales & Marketing | Sale | −23,429 | $6.94 | $163K | 0 |
| 2022-11-01 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion · Employee Stock Option (right to buy) | −23,429 | 4,438 | ||
| 2022-10-11 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion | +4,282 | $0.84 | $4K | 4,282 |
| 2022-10-11 | Ross Thomas M. EVP, Global Sales & Marketing | Sale | −4,282 | $6.51 | $28K | 0 |
| 2022-10-11 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion · Employee Stock Option (right to buy) | −4,282 | 27,867 | ||
| 2022-10-10 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion | +24,851 | $0.84 | $21K | 24,851 |
| 2022-10-10 | Ross Thomas M. EVP, Global Sales & Marketing | Sale | −24,851 | $6.45 | $160K | 0 |
| 2022-10-10 | Ross Thomas M. EVP, Global Sales & Marketing | Exercise or conversion · Employee Stock Option (right to buy) | −24,851 | 32,149 | ||
| 2022-10-03 | Casdin Partners Master Fund, L.P. 10% owner | Sale | −735,786 | $6.15 | $4.5M | 10,000,000 |
| 2022-07-01 | Casdin Partners Master Fund, L.P. 10% owner | Sale | −3,235,548 | $4.30 | $13.9M | 10,735,786 |
| 2022-06-29 | Al-Wakeel Yasir B. Director | Grant or award · Stock Option (right to buy) | +26,900 | 26,900 | ||
| 2022-06-29 | DOUGLAS RICHARD Director | Grant or award · Stock Option (right to buy) | +26,900 | 26,900 | ||
| 2022-06-29 | Brooke William W Director | Grant or award · Stock Option (right to buy) | +26,900 | 26,900 | ||
| 2022-06-29 | Erck Stanley C Director | Grant or award · Stock Option (right to buy) | +26,900 | 26,900 |
Page 17 of 21 · 411 trades